The editorial 'Why look backwards?' by Mark Kurusz 1 can be seen as a landmark that summarizes the human dimension of more than a half-century history of extracorporeal life support. Extracorporeal life support has made a quantum leap during the last two decades. Development of safer extracorporeal technology stimulated the spread of cardiac surgical procedures throughout the world, as well as the development of new surgical methods, widened the types of treated pathology, and extended the age limits of patients treated. One of the powerful stimuli in the explosive innovation in extracorporeal technology was the re-introduction of 'off-pump' coronary bypass surgery in the early 1990s. Promising results of the first two large series on 'offpump' coronary bypass surgery, economic reasons 2,3 , and the interest in minimally invasive coronary surgery through mini-thoracotomy approaches as well, encouraged the adoption of this technique throughout the world 4 .The decreasing demand for cardiopulmonary bypass procedures with the wide use of 'off-pump' methods acted as a stimulus for inventions such as new blood-surface coatings, resulting in more efficient and biocompatible oxygenators and systems. Blood-saving methods and techniques for preventing haemodilution were developed and found recognition worldwide during this period as well. Moreover, enhanced biocompatibility and robust extracorporeal equipment (re)opened exceptionally wide horizons for extracorporeal life support in intensive care therapy, resuscitation, oncology, organ preservation, and invasive cardiology, in addition to traditional applications in cardiac and vascular surgery.
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Despite tremendous progress in equipment and the expanding areas where the methods of extracorporeal life support are applicable, the structure of the profession, as well as the theory behind extracorporeal life support, is now just making the first uncertain steps from the primary seas of protoscience to the shore sands of established and well-respected science. Science as a systematic enterprise that builds and organizes knowledge in the form of testable explanations and predictions definitely exists in extracorporeal life support methodology. However, still, even the everyday routine cardiopulmonary bypass procedure for cardiac surgery demands not only broad knowledge, but also 'hands-on' experience, fast deductive reasoning and, in part, something indefinable. Patient survival is often determined in the minutes it takes for cellular death to occur due to ischemia. So, it is a one shot deal, without any chance for replay. In other words, a perfusionist must provide mastery to even routine cardiopulmonary bypass to bring about a satisfactory outcome. A gigantic divergence between the newest, highly sophisticated equipment, fast expansion in new fields of activities, and limited understanding of involved processes attracts and demands more and more attention today 5, 6 .
The sometimes 'lagging behind' in perfusion technology can be related to the relatively late germination of technology and sometimes feigned absence of a niche in an academic level of the medical science structure. However, the interdisciplinary nature of required knowledge and, inherent with this, obstacles in formation and development of science are most important. Perfusion technology or, as more commonly used by most authors and clinicians, cardiovascular perfusion, can be defined as a profession that combines technical expertise and medical knowledge 5 Perfusion 27 (2) scientific specialties, encompassing, among others, biology, physiology, pathophysiology, biochemistry, physics, bioengineering, and medical science. The interdisciplinary nature of this emerging profession is reflected in a wide diversity of required backgrounds of new recruits. The task of the new generation is not simpler than the task of the pioneers. This task is to melt diverse ingots of knowledge from a wide range of academic fields into a single discipline.
It is absolutely right that the 'war stories' of the first generation become historical footnotes with development of new technologies and extensive accumulation and sharing of experience and knowledge. However, what we cannot forget, put into footnotes, is the spirit, good will, and dedication of the pioneers. We must preserve and foster their devotion to the coming generations.
